AbbVie, Novartis Sue Wash. Over New 340B Drug-Pricing Law
By Rachel Riley · March 25, 2026, 9:38 PM EDT
Pharmaceutical giants Novartis and AbbVie say a new Washington state law illegally expands drugmakers' obligations to provide deeply discounted medications under the federal government's 340B Drug Pricing Program, according to a...
To view the full article, register now.